{
  "id": "menieres-disease",
  "title": "Ménière’s disease",
  "lang": "en",
  "source_lang": "en",
  "summary": "Ménière’s disease is an inner-ear disorder characterized by recurrent vertigo, fluctuating sensorineural hearing loss, tinnitus, and ear fullness.",
  "category": "health",
  "subcategory": "diseases",
  "type": "concept",
  "aliases": [
    "Meniere disease",
    "Ménière disease",
    "Meniere’s disease"
  ],
  "generated_at": "2026-11-05",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/menieres-disease/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/menieres-disease/",
      "json": "https://aiwiki.page/zh/menieres-disease.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Ménière’s disease is a chronic disorder of the inner ear characterized by spontaneous attacks of vertigo, fluctuating sensorineural hearing loss, tinnitus, and a sensation of pressure or fullness in the affected ear. It usually begins in one ear, although both ears can become involved. Attacks occur unpredictably and can substantially disrupt mobility, communication, work, and everyday activities.\n\nThe disease is closely associated with endolymphatic hydrops, an enlargement of the inner ear’s endolymph-containing spaces. Hydrops is an important pathological finding, but it does not by itself explain every symptom or establish the diagnosis. Diagnosis rests principally on the pattern and duration of attacks, documented hearing changes, and exclusion of alternative disorders. Treatment addresses several distinct problems: acute vertigo, recurrent attacks, progressive auditory impairment, and persistent imbalance. There is no established treatment that reliably reverses the underlying disease or restores hearing already lost."
    },
    {
      "heading": "Historical recognition and epidemiology",
      "text": "In 1861, the French physician Prosper Ménière argued that a characteristic combination of vertigo, deafness, and abnormal ear noises could originate in the inner ear rather than the brain. This was a major shift from explanations that attributed such episodes primarily to cerebral congestion or other intracranial disturbances. His work established an anatomical framework for recognizing disorders in which hearing and balance symptoms arise together. The modern disease category developed subsequently and is narrower than the full range of cases discussed in early descriptions.\n\nA second milestone came in 1938, when temporal-bone studies by the Japanese physician Kyoshiro Yamakawa and, independently, the British investigators Charles Hallpike and Hugh Cairns described enlargement of endolymphatic spaces in affected ears. These observations linked the clinical syndrome to a reproducible anatomical abnormality. For much of the twentieth century, however, this finding could be demonstrated mainly after death. Later developments in contrast-enhanced inner-ear imaging made it possible to investigate related changes in living patients.\n\nMénière’s disease most commonly becomes apparent in middle adulthood, often between approximately 40 and 60 years of age, but it can occur outside this range. Childhood onset is uncommon. Some population studies report a modest female predominance, although sex distributions vary with setting and diagnostic method. Reported prevalence differs substantially between countries and studies, from tens to several hundred cases per 100,000 people. These estimates are not directly interchangeable: administrative diagnostic codes, self-reported diagnoses, and specialist-confirmed cases identify different populations.\n\nSeveral features complicate its epidemiology. Early disease may present with hearing symptoms before recognizable vertigo, or with vestibular episodes before an audiogram captures hearing loss. Conversely, other recurrent dizziness disorders may be labeled Ménière’s disease without meeting formal criteria. Specialist referral cohorts also overrepresent severe, persistent, or diagnostically complex illness. Estimates of bilateral involvement depend strongly on follow-up duration and on whether involvement of the second ear requires the complete clinical syndrome or only auditory abnormalities.\n\nMost cases occur without an identified affected relative. Familial clustering nevertheless occurs in a minority, supporting a genetic contribution in some families. Family histories can be difficult to interpret because relatives may have migraine, nonspecific dizziness, isolated hearing impairment, or incompletely documented disease rather than the same syndrome. Ménière’s disease is therefore best understood epidemiologically as a heterogeneous clinical disorder, not as a single condition with one uniform inherited or environmental cause."
    },
    {
      "heading": "Inner-ear physiology and proposed disease mechanisms",
      "text": "The inner ear contains the cochlea, which transduces sound, and vestibular organs that detect head movement and orientation. These structures include fluid-filled membranous compartments containing endolymph, surrounded by spaces containing perilymph. Endolymph has a distinctive ionic composition, with a high potassium concentration that supports sensory transduction. Specialized epithelial tissues maintain these gradients through selective transport and electrical barriers. Normal hearing and balance therefore depend on tightly regulated fluid composition, compartment geometry, and sensory-cell function.\n\nThe cochlea converts sound-driven mechanical movement into electrical signals through sensory hair cells. The vestibular apparatus uses related cells in the semicircular canals and otolith organs to detect angular acceleration, linear acceleration, and gravity. Unequal vestibular signals from the two ears can create an erroneous sensation of movement, with associated eye movements and postural disturbance. Because the cochlear and vestibular compartments share the membranous labyrinth, a disorder affecting endolymph regulation can plausibly produce both auditory and balance symptoms.\n\nEndolymphatic hydrops refers to distension of endolymph-containing spaces. It is strongly associated with Ménière’s disease in temporal-bone studies, but the relationship is not one-to-one. Hydrops can occur in other ear disorders and in ears without the complete clinical syndrome. Its presence therefore does not prove that it is the immediate cause of an attack. The endolymphatic sac and duct are involved in inner-ear fluid and immune regulation, but the disease cannot be reduced to a simple blockage of a drainage tube.\n\nOne influential hypothesis proposes that distension sometimes disrupts membranous barriers, allowing potassium-rich endolymph to mix with surrounding fluid and transiently disturb sensory and nerve activity. This membrane-rupture model explains some features of abrupt attacks but has not been established as a universal mechanism. Other models emphasize altered ion transport, abnormal electrical homeostasis, mechanical distortion of sensory structures, and changes in inner-ear blood–tissue barriers. Repeated dysfunction and structural injury may eventually produce more permanent hearing and balance deficits.\n\nPotential upstream contributors include inherited susceptibility, immune-mediated processes, and inflammatory responses. Research has identified candidate genetic variants in selected families, but no single gene explains most cases. Associations with migraine, allergy, and autoimmune disease have also been reported. Such associations do not establish a common mechanism in every patient. Ménière’s disease may represent several biological pathways converging on a similar pattern of inner-ear dysfunction, which helps explain its variable course and inconsistent response to treatment."
    },
    {
      "heading": "Clinical manifestations and natural history",
      "text": "The defining vestibular event is a spontaneous episode of vertigo, often described as rotation, tilting, or movement of the surroundings. An attack can be accompanied by nausea, vomiting, sweating, and marked difficulty standing or walking. Symptoms generally evolve over minutes rather than consisting solely of a momentary positional sensation. Under contemporary criteria for definite disease, qualifying vertigo episodes last from 20 minutes to 12 hours. Residual unsteadiness or exhaustion may persist after the main spinning sensation has subsided.\n\nAuditory symptoms usually localize the disorder to an affected ear. Early hearing loss often fluctuates and disproportionately affects low frequencies, although this pattern is neither universal nor permanently maintained. A person may notice muffled hearing, distortion, reduced clarity, or a change in sound quality rather than simply reduced loudness. Tinnitus may resemble roaring, buzzing, or ringing. Aural fullness can accompany an attack or occur between attacks; some patients notice increasing fullness or tinnitus before vertigo, but a reliable warning is not always present.\n\nThe relationship among symptoms changes over time. Hearing may improve after an early attack, while repeated episodes can be followed by incomplete recovery. Audiograms may eventually show a broader, flatter pattern of sensorineural impairment rather than predominantly low-frequency loss. Speech understanding can deteriorate, and increasing loudness does not necessarily restore clarity. The degree of hearing impairment does not reliably predict the frequency or severity of vestibular attacks.\n\nThe disease often follows an irregular course, with clusters of attacks separated by weeks, months, or longer periods of relative stability. Vertigo may become less frequent over years even while hearing impairment persists or progresses. This does not mean that the ear has returned to normal: reduced episodic activity may coexist with chronic vestibular weakness, movement sensitivity, or persistent imbalance. Some patients remain relatively mildly affected, whereas others develop substantial disability. In bilateral disease, loss of vestibular reserve can make compensation especially difficult.\n\nAn uncommon manifestation is a sudden vestibular drop attack, traditionally called a Tumarkin attack. Abrupt abnormal signaling from the otolith organs can produce a sensation of being pushed or thrown, causing a fall without the loss of consciousness characteristic of fainting. These events are distinct from ordinary prolonged vertigo attacks and carry an injury risk. Persistent neurological deficits, actual loss of consciousness, and many other causes of falling are not characteristic features of Ménière’s disease itself and require separate diagnostic explanations."
    },
    {
      "heading": "Diagnostic criteria and clinical investigations",
      "text": "The diagnosis is clinical, supported by audiometry rather than by a single definitive laboratory test. International consensus criteria published in 2015 distinguish definite from probable Ménière’s disease. Definite disease requires at least two spontaneous vertigo episodes, each lasting 20 minutes to 12 hours; audiometrically documented low- to medium-frequency sensorineural hearing loss in one ear on at least one occasion before, during, or after a vertigo episode; fluctuating aural symptoms in that ear; and no better explanation by another vestibular diagnosis.\n\nProbable disease is a broader category. It requires at least two episodes of vertigo or dizziness lasting 20 minutes to 24 hours, fluctuating aural symptoms in the affected ear, and exclusion of a better explanation. Unlike definite disease, it does not require the same audiometric documentation. This distinction accommodates patients whose evolving symptom pattern is suggestive but does not yet satisfy the more specific definition. A single episode of vertigo with tinnitus, or isolated hydrops on imaging, is insufficient for definite disease.\n\nA detailed medical history establishes attack duration, spontaneity, auditory laterality, fluctuation, associated migraine features, and symptoms between episodes. The physical examination may be normal between attacks. During an episode, spontaneous nystagmus—rhythmic involuntary eye movement—may be present. Neurological examination and assessment of gait help distinguish peripheral vestibular symptoms from central disorders. Serial audiometry is particularly informative because a single test can miss fluctuating hearing loss. Speech testing adds information about functional hearing beyond pure-tone thresholds.\n\nVestibular testing can characterize impairment but does not independently establish Ménière’s disease. Caloric testing evaluates predominantly low-frequency responses of the horizontal semicircular canal, whereas the video head impulse test measures responses to faster head movements. Some affected ears show reduced caloric responses despite relatively preserved head impulse responses. Vestibular-evoked myogenic potentials assess pathways involving the otolith organs. These patterns can support physiological characterization, but they overlap with other conditions and vary with disease stage.\n\nMagnetic resonance imaging may be used to evaluate asymmetric sensorineural hearing loss and exclude retrocochlear abnormalities such as vestibular schwannoma. Specialized delayed imaging after administration of a gadolinium-based contrast agent can visualize features consistent with hydrops in some centers. This is distinct from a routine brain MRI and is not a substitute for clinical criteria. Electrocochleography, which records cochlear and auditory-nerve electrical responses, has also been studied, but variable methods and imperfect diagnostic performance limit its routine diagnostic role."
    },
    {
      "heading": "Disorders with overlapping symptoms",
      "text": "The differential diagnosis is broad because vertigo, tinnitus, and hearing fluctuation are not unique to Ménière’s disease. Episode duration, auditory findings, triggers, neurological symptoms, and the relationship between symptoms are more informative than any single complaint. The presence of one established disorder does not exclude another: positional vertigo or migraine-related episodes can occur in someone who also has Ménière’s disease.\n\nVestibular migraine is a particularly important alternative. Its episodes may last from 5 minutes to 72 hours and are associated, in a defined proportion of attacks, with migraine features such as characteristic headache, sensitivity to light and sound, or visual aura. Auditory symptoms can occur, making symptom-based distinction difficult. Documented unilateral low-frequency hearing loss and a typical cochlear–vestibular sequence favor Ménière’s disease, but no single feature resolves every case. Some patients meet criteria for both disorders, and migraine symptoms can accompany a Ménière attack.\n\nBenign paroxysmal positional vertigo usually produces brief, position-triggered attacks associated with characteristic positional nystagmus. It does not ordinarily produce fluctuating sensorineural hearing loss. Vestibular neuritis typically causes a prolonged acute vestibular syndrome lasting days rather than recurrent attacks accompanied by cochlear symptoms. Labyrinthitis can affect both hearing and balance, but its usual acute course differs from the recurring pattern used to define Ménière’s disease. Sudden sensorineural hearing loss is likewise a separate clinical syndrome, even when tinnitus or vertigo accompanies it.\n\nStructural disorders can produce additional overlap. Vestibular schwannoma, a usually benign tumor arising from vestibular nerve Schwann cells, commonly causes asymmetric hearing impairment or unilateral tinnitus and sometimes imbalance. Superior semicircular canal dehiscence can cause sound- or pressure-induced vertigo, abnormal perception of internally generated sounds, and characteristic hearing-test findings. Perilymphatic fistula is considered in selected circumstances involving trauma, pressure change, or surgery, although its diagnosis can be difficult. Autoimmune inner-ear disease more often produces progressive or fluctuating hearing loss over weeks to months, frequently involving both ears.\n\nCentral and functional vestibular disorders require different distinctions. Posterior circulation stroke can cause acute vertigo and sometimes hearing loss, particularly when the inner-ear blood supply is involved; associated neurological signs may help identify a central process, but their absence does not exclude one. Persistent postural-perceptual dizziness produces chronic nonspinning dizziness or unsteadiness, typically aggravated by upright posture, movement, and complex visual environments. It can develop after an episodic vestibular illness and coexist with Ménière’s disease rather than replacing the original diagnosis."
    },
    {
      "heading": "Nonablative medical management",
      "text": "Medical management separates relief of an ongoing attack from attempts to reduce future attacks. Acute treatment does not necessarily alter the underlying disease, and prevention of vertigo does not necessarily preserve hearing. The 2020 clinical practice guideline of the American Academy of Otolaryngology–Head and Neck Surgery Foundation organizes care around this distinction, while also addressing hearing rehabilitation, persistent imbalance, and escalation for continuing active disease. Treatment studies vary substantially in quality, and many commonly used measures have less certain evidence than their long clinical history might suggest.\n\nDuring acute attacks, clinicians may use short courses of vestibular-suppressant and antiemetic medicines. Some antihistamines reduce motion-related symptoms, while other agents act through different central pathways. These drugs principally target vertigo, nausea, and vomiting. Sedation and impaired coordination are relevant adverse effects. Prolonged vestibular suppression is different from short-term attack treatment because it can interfere with adaptation to vestibular deficits and add medication-related imbalance.\n\nDietary and lifestyle measures have traditionally included sodium restriction, moderation of caffeine or alcohol, regular meals, and attention to sleep. Their proposed mechanisms include reducing fluctuations in fluid regulation or avoiding individually associated symptom triggers. However, rigorous evidence that a specific sodium target or universal exclusion diet prevents Ménière attacks is limited. Reported associations between stress and symptoms are also difficult to interpret: distress may precede episodes, follow them, or reflect a common accompanying process. These associations do not establish that the disorder is psychological.\n\nDiuretics are used in some settings with the aim of modifying fluid balance, often through a thiazide-based preparation, sometimes combined with a potassium-sparing agent. Their physiological effects are well established, but evidence for a specific disease-modifying effect in Ménière’s disease remains uncertain. Betahistine is widely used in some countries and is not approved by the United States Food and Drug Administration. It acts at histamine receptors and has proposed vascular and vestibular effects. In the 2016 BEMED placebo-controlled trial, neither of the studied betahistine regimens showed a significant advantage over placebo for the primary vertigo-attack outcome.\n\nSystemic corticosteroids have been used in selected circumstances, but they are not an established universal long-term treatment for Ménière’s disease. Other medications directed at presumed viral, allergic, or immune mechanisms have also been investigated without establishing a generally effective disease-specific regimen. Treatment of a coexisting condition, such as migraine, addresses that condition rather than proving that all of the patient’s symptoms share one cause. Across medical approaches, documentation of attack frequency, hearing, adverse effects, and functional limitations is essential to interpreting apparent benefit."
    },
    {
      "heading": "Intratympanic treatment and surgery",
      "text": "For continuing active disease, treatment can be delivered directly into the middle ear through the tympanic membrane. The drug then reaches the inner ear in part by diffusion across the round-window membrane. This approach achieves local exposure while limiting some systemic effects, but delivery to the relevant inner-ear tissues is variable. Intratympanic procedures have different purposes: corticosteroids aim to reduce symptoms without intentionally destroying vestibular function, whereas gentamicin deliberately reduces vestibular activity in the treated ear.\n\nIntratympanic corticosteroid injections, commonly using dexamethasone or methylprednisolone, are used as a nonablative option. Proposed actions include modification of inflammatory activity and inner-ear ion transport. Clinical studies differ in drug formulation, concentration, injection schedule, comparison group, and definitions of response. Consequently, estimates of benefit are uncertain. Potential complications include discomfort, transient dizziness, infection, and persistent tympanic-membrane perforation. The procedure is not reliably associated with restoration of established sensorineural hearing loss.\n\nGentamicin is an aminoglycoside antibiotic with toxic effects on inner-ear sensory structures, particularly vestibular hair cells under commonly used local regimens. Intratympanic gentamicin seeks to reduce erratic vestibular signaling from the affected ear and thereby control vertigo. Dose schedules range from fixed courses to response-guided administration. The intended vestibular reduction requires subsequent central compensation, and persistent imbalance can occur. Cochlear toxicity is also possible, so hearing deterioration remains an important risk even when low-dose approaches are used.\n\nSeveral operations have been developed for refractory disease. Endolymphatic sac decompression or shunt procedures aim to alter conditions around the sac without deliberately destroying the labyrinth. Their specific efficacy is uncertain because controlled evidence is limited and symptoms can improve without active surgery. Vestibular nerve section interrupts vestibular input while attempting to preserve cochlear nerve function and hearing. It is an intracranial operation with risks that can include cerebrospinal-fluid leakage, infection, and injury to adjacent structures.\n\nLabyrinthectomy removes or disables the vestibular sensory apparatus of the affected inner ear and sacrifices remaining hearing in that ear. It is therefore generally reserved for selected cases with nonusable hearing and persistent disabling vertigo. The status of the opposite ear matters particularly for any ablative intervention: bilateral vestibular impairment can cause enduring difficulty with walking, balance in darkness, and visual stability during head movement. Surgical outcomes must also be distinguished by domain. A procedure may substantially reduce vertigo yet leave tinnitus, auditory disability, or chronic disequilibrium unchanged."
    },
    {
      "heading": "Hearing, balance rehabilitation, and functional consequences",
      "text": "Ménière’s disease can cause disability between attacks as well as during them. Unpredictability affects travel, employment, household responsibilities, and participation in social activities. Auditory distortion can make conversation difficult even when sounds remain audible, while unilateral impairment reduces sound localization and speech understanding in noisy environments. Tinnitus and recurrent sleep disruption can add to the burden. Measures of health-related quality of life therefore capture aspects of illness not represented by an audiogram or a count of vertigo episodes.\n\nHearing aids can improve access to sound when residual hearing is sufficient, but fluctuating thresholds complicate fitting. Adjustable programs and follow-up testing can accommodate changes in amplification needs. Amplification cannot fully correct the loss of frequency selectivity or speech clarity caused by cochlear injury. Assistive listening technologies, including remote microphone systems, can improve the signal-to-noise ratio in particular settings. Communication difficulty also depends on the listening environment and on whether one or both ears are affected.\n\nFor severe or profound hearing loss with limited benefit from hearing aids, cochlear implantation is an established hearing-rehabilitation option in appropriately selected patients. The implant bypasses damaged hair-cell transduction by electrically stimulating auditory nerve fibers. Ménière’s disease does not by itself prevent useful implant outcomes, although individual results depend on several auditory and clinical factors. Implantation can occur separately from vestibular treatment or, in selected cases, in association with an ablative procedure. Hearing restoration and vertigo control remain distinct outcome goals.\n\nVestibular rehabilitation addresses persistent imbalance rather than terminating a fluctuating acute attack. Exercise-based programs use gaze-stabilization tasks, graded head movement, balance training, and walking activities to promote adaptation and substitution. The central nervous system combines vestibular, visual, and somatosensory information; rehabilitation exploits this flexibility when one source is impaired. Recurrent fluctuations may complicate compensation, while a stable deficit after ablation can provide a more consistent target for training. Bilateral deficits generally require broader compensatory strategies than unilateral weakness.\n\nThe psychological consequences of recurrent vertigo are substantial but should not be confused with its origin. Anticipatory distress, avoidance of activity, and symptoms of anxiety or depression can coexist with objectively documented inner-ear disease. Persistent postural-perceptual dizziness may also become an additional source of disability after repeated attacks. Clinical assessment separates these overlapping contributors rather than attributing every ongoing symptom to active hydrops. Functional outcomes depend on auditory support, vestibular compensation, comorbid conditions, and environmental demands as well as on the frequency of Ménière attacks themselves."
    },
    {
      "heading": "Research methods and unresolved questions",
      "text": "A central research challenge is deciding whether Ménière’s disease represents one biological disease or several mechanisms with a shared clinical presentation. Studies have proposed subgroups based on family history, migraine, autoimmune comorbidity, bilateral involvement, and the sequence of auditory and vestibular symptoms. These classifications may help organize research, but they have not yet produced a universally accepted system that reliably selects an effective treatment. Candidate genetic and inflammatory findings require replication across populations and careful separation of association from causation.\n\nImaging has created opportunities to connect symptoms with inner-ear structure. Delayed contrast-enhanced MRI can estimate the relative extent of endolymphatic spaces, but results depend on acquisition protocols, timing, grading systems, and reader interpretation. Hydrops severity does not map perfectly onto attack activity or functional impairment. A structural imaging abnormality is therefore not automatically a validated biomarker of treatment response. Longitudinal studies are needed to establish which imaging changes precede symptoms, follow injury, or remain clinically silent.\n\nClinical trials face the disease’s spontaneous fluctuations. Patients often enter studies when attacks are particularly frequent, after which attack frequency may decline regardless of treatment. This produces regression to the mean. Expectation, concurrent care, and changes in symptom reporting can contribute additional apparent improvement. A randomized controlled trial helps distinguish these effects from a treatment-specific effect, but adequate sample sizes and long follow-up are difficult to obtain for an uncommon and variable disorder.\n\nOutcome selection is another major problem. Vertigo days, number of discrete attacks, attack intensity, hearing thresholds, speech recognition, tinnitus burden, and functional disability measure different aspects of the illness. A treatment can improve one without improving another. Historical studies often used differing diagnostic criteria and vertigo-control classifications, making comparison difficult. Contemporary work increasingly combines objective hearing and vestibular measures with patient-reported outcomes, while distinguishing active episodic disease from chronic residual impairment.\n\nLong-term safety is particularly important for interventions that alter vestibular function irreversibly. Short-term attack suppression does not capture later bilateral disease, persistent disequilibrium, or hearing decline. Conversely, a modest change in attack count may conceal a meaningful reduction in severe vomiting episodes or falls. Current unresolved questions include the initiating causes of hydrops, the mechanism that converts a chronic structural abnormality into an abrupt attack, predictors of second-ear involvement, and whether any intervention can preserve cochlear function rather than merely suppress vertigo."
    }
  ],
  "links": [
    "hearing-loss",
    "tinnitus",
    "brain",
    "prevalence",
    "epidemiology",
    "gene",
    "migraine",
    "allergy",
    "autoimmune-disease",
    "nausea",
    "diagnosis",
    "medical-history",
    "physical-examination",
    "magnetic-resonance-imaging",
    "gadolinium-based-contrast-agent",
    "differential-diagnosis",
    "stroke",
    "antihistamine",
    "corticosteroid",
    "surgery",
    "health-related-quality-of-life",
    "rehabilitation",
    "central-nervous-system",
    "depression",
    "biomarker",
    "randomized-controlled-trial",
    "patient-reported-outcome"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}